Together, our mission is to accelerate the development of breakthrough drugs that are more efficacious and less toxic
Founder and CEO, Board Director
Luke Blauch, Ph. D.
Luke is a pioneer and expert in performing high-throughput single cell screens of function with microfluidics. Luke did his Ph. D. at Stanford University and has previously worked at a number of venture-funded biotech startups.
Chief Strategy Officer, Board Director
Megan Yung
Megan is a corporate strategist who has built and defended IP portfolios of over 1000 patents and applications, including handling some of the most well-known biotech portfolios of recent times.
Scientific Advisor
Howard Bernstein, M.D. Ph. D.
Howard is a member of the National Academy of Engineering and inventor on >300 patents with decades of experience in early and late-stage clinical filings. Most recently he was CSO and Interim CEO of SQZ Biotech.
